Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Current and future insights in H. pylori eradication regimens: the need of tailoring therapy.

Current pharmaceutical design - 1 Jan 2014

Papastergiou Vasilios, Georgopoulos Sotirios D, Karatapanis Stylianos

Abstract excerpt

Treatment of Helicobacter pylori (H. pylori) infection is crucial for the management of prevalent digestive and more recently also extra-digestive disorders. Rising prevalence of clarithromycin resistance worldwide has accounted for a dramatic decline in the efficacy of standard triple therapies, which should not be prescribed, unless local clarithromycin-resistance is low (<20%) or culture confirms...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Bacterial Agents
Share to Clarithromycin
Share to Drug Resistance, Bacterial

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Therapy, Combination

Share to Helicobacter Infections

Share to Helicobacter pylori

Share to Microbial Sensitivity Tests

Share to Pharmacogenetics

Source

Identifiers

PMID: 24180408
DOI: 10.2174/13816128113196660726

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Current and future insights in H. pylori eradication regimens: the need of tailoring therapy.PMID 24180408Read ↗

Treatment of Helicobacter pylori infection: meeting the challenge of antimicrobial resistance.Semantic proximity Read ↗

Importance of antimicrobial susceptibility testing for the management of eradication in Helicobacter pylori infection.Semantic proximity Read ↗

Tailored versus Triple plus Bismuth or Concomitant Therapy as Initial Helicobacter pylori Treatment: A Randomized Trial.Semantic proximity Read ↗

Efficacy of genotypic susceptibility-guided tailored therapy for Helicobacter pylori infection: A systematic review and single arm meta-analysis.Semantic proximity Read ↗

Novel and Effective Therapeutic Regimens for Helicobacter pylori in an Era of Increasing Antibiotic Resistance.Semantic proximity Read ↗

Efficacy of tailored Helicobacter pylori eradication therapy based on antibiotic susceptibility and CYP2C19 genotype.Semantic proximity Read ↗

Appropriate first-line regimens to combat Helicobacter pylori antibiotic resistance: an Asian perspective.Semantic proximity Read ↗

Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: a multicentre clinical trial.Semantic proximity Read ↗

Next Generation Sequencing for the Prediction of the Antibiotic Resistance in Helicobacter pylori: A Literature ReviewSemantic proximity Read ↗

Multiple-antibiotic-resistant Helicobacter pylori infection eradicated with a tailor-made quadruple therapy.Semantic proximity Read ↗

High antibiotic resistance rate: A difficult issue for Helicobacter pylori eradication treatment.Semantic proximity Read ↗

Attempts to enhance the eradication rate of Helicobacter pylori infection.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.